Background-We have shown that the calmodulin inhibitor W-7 suppresses torsade de pointes (TdP) without shortening the QT interval, which is consistent with other findings that QT prolongation, per se, is insufficient to generate TdP. ECGs were analyzed from a well-characterized animal model of TdP to identify more reliable predictors of this life-threatening ventricular arrhythmia. Methods and Results-TdP was induced using methoxamine and clofilium in 12 of 14 rabbits pretreated with vehicle control, whereas pretreatment with W-7 (50 mol/kg), an inhibitor of the intracellular Ca 2ϩ -binding protein calmodulin, significantly suppressed TdP induction (1 of 11 rabbits with TdP, PϽ0.001). W-7 did not affect heart rate, increases in QT intervals, or dispersion compared with measurements in vehicle-treated control animals. However, a progressive and significant increase in the ratio of U-wave to T-wave amplitude (UTA) occurred before TdP onset in control animals, and this was prevented by W-7. Conclusions-Selective suppression of TdP inducibility by W-7, without shortening the duration of cardiac repolarization, allowed identification of the UTA ratio as a new electrocardiographic index for predicting TdP onset. These findings are consistent with the idea that prolonged repolarization is not the proximate cause of arrhythmia initiation, and they suggest that an increased UTA ratio reflects activation of intracellular Ca 2ϩ /calmodulin-dependent processes that are required for triggering TdP in this model. 
T orsade de pointes (TdP) is a form of polymorphic ventricular tachycardia usually initiated after QT prolongation and bradycardia. It is associated with sudden cardiac death both in the congenital form 1, 2 and in the acquired long-QT syndrome, which often is provoked by action potential-prolonging drugs. 3, 4 TdP remains an important clinical challenge because of increasing recognition of congenital long-QT syndromes and the ongoing risk posed to millions of patients taking QT intervalprolonging drugs. Identification of the molecular triggers for TdP is an area of active inquiry, and a growing body of work has highlighted the importance of intracellular calcium signaling for induction of TdP. [5] [6] [7] [8] [9] [10] [11] Increased calcium activates many intracellular targets, including the calcium-binding protein calmodulin (CaM), and the CaM inhibitor W-7 was recently reported to suppress TdP induction without shortening the QT duration. 9 This observation suggested the possibility that W-7 could be used as a probe to test the hypothesis that electrocardiographic parameters linked to CaM-dependent cellular signaling could predict the development of TdP.
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Presently available electrocardiographic parameters are unsatisfactory for predicting TdP onset, and improved TdP predictors are needed for prevention and timely treatment of this life-threatening arrhythmia. QT dispersion (QTd) is one electrocardiographic parameter that has been reported to reflect heterogeneity of ventricular repolarization, and increased QTd is associated with malignant ventricular arrhythmias in patients with structural heart disease, 12 excessive QT prolongation from antiarrhythmic drugs, 13 and in the congenital long-QT syndromes. 14, 15 However, the independent prognostic significance of QTd is uncertain. Furthermore, all ECG duration measurements are complicated by the difficulty in precisely and accurately determining the end of the T or U wave. 16, 17 The previously reported finding that W-7 could suppress TdP without shortening the QT indicated that QT prolongation is not the proximate cause of TdP. However, W-7's effects on other electrocardiographic repolarization parameters, including QTd, are unknown. This study was undertaken to test the hypothesis that electrocardiographic parameters predictive of TdP initiation and reflecting the CaM-activated molecular machinery for triggering TdP are revealed by W-7.
Methods

Rabbit Arrhythmia Model
The in vivo rabbit model of TdP was adapted from Carlsson et al 18 with minor modifications as previously described. 9 Male New Zealand rabbits (2.5 to 3.5 kg) (Myrtle's Rabbitry, Thompson's Station, Tenn) were anesthetized with ketamine (35 mg/kg IM) and xylazine (5 mg/kg IM). Supplemental xylazine (1 mg/kg IM) and ketamine (15 mg/kg IM) were given 15 minutes after the initial doses to maintain adequate anesthesia (loss of withdrawal reflex) throughout the experiment. Rabbits were mechanically ventilated with room air (Harvard Rodent Ventilator), and arterial blood pressure was continuously monitored via a femoral artery cannula. There were no significant differences in systolic or diastolic arterial pressure in W-7-or vehicle-treated groups, similar to a previous report. 9 Methoxamine (70 nmol/kg per minute) in vehicle solution (5% dextrose, 20 mL IV total) was infused for controls; W-7 (50 g/kg in 20 mL IV total; Biomol) was infused for the experimental group during the first 10 minutes (Figure 1 ). Thereafter, clofilium (100 nmol/kg per minute) and methoxamine were infused together for 30 minutes or until TdP induction occurred (Figure 1 ). After the study, animals were euthanized with pentobarbital (50 mg/kg IV) and KCl (1 mL, 3 mol/L IV). All procedures were approved by the Vanderbilt University Animal Care Committee.
ECG Recording
Standard surface ECG limb leads (I, II, III, aVF, aVL, aVR), a midsternal chest lead (V 1 ), and a midaxillary chest lead (V 6 ) were monitored continuously and digitally acquired (499-Hz sampling) with a personal computer using a 12-lead ECG amplifier and Ponemah software (both from Gould Instrument Systems). Records from 4 control and 2 W-7 experiments were deleted before complete ECG interval analysis because of difficulties with an early version of this software. TdP was defined as Ն6 consecutive beats of polymorphic ventricular tachycardia (Figure 2 ).
ECG Interval Measurements
QT measurements were recorded from the onset of the QRS complex to the return of the T wave to the isoelectric line but also included the U wave when present at Ն25% of the T-wave amplitude. 9, 19 QT intervals were measured for 3 consecutive sinus beats at 6 consecutive 4-minute intervals and at 30 minutes, or until the occurrence of bigeminy or sustained TdP. The QT was corrected for variation in heart rate (QTc) using the following formula developed for rabbits: QTcϭQTϪ0.175(RRϪ300). 20 QTd was defined as the longest QT interval minus the shortest QT interval (also including the U wave when present, as above) among 8 leads. The dispersion values were calculated for each beat separately, and QTd is the mean for 3 consecutive sinus beats analyzed. All measurements were performed manually with an online electronic caliper at 50-mm/s sweep speed to improve resolution of T-and U-wave terminal segments.
RR Interval
The RR interval was measured from the onset of consecutive QRS complexes.
T-and U-Wave Analysis
The amplitudes of the T and U waves were analyzed in the lead with the highest U-wave amplitude and the clearest distinction between the T and U waves, according to a previously published method with minor modifications. 21 Development of U waves was judged independently by 2 observers who were blinded to treatment status 30 seconds before the first premature ventricular contraction (PVC) or at the end of the experiment (Figure 1 ), whichever came first. A distinct U wave had to be visualized in at least 2 limb leads and was graded from 0 to 2. A grade of 0 meant no U wave was present. Grade 1 indicated 2 distinct components of repolarization were identified, as defined by 2 tangent lines, each with a slope equal to 0, where the repolarization components were not separated by a clear nadir point. Grade 2 indicated that distinct T-and U-wave forms were present and separated by a nadir point. The ratio of U-wave to T-wave amplitude (UTA) was analyzed, by design, if the 2 observers blinded to the treatment status gave a combined score Ն3 but there were no interobserver disagreements.
Chemicals
Chemicals were obtained from Sigma unless otherwise noted. Solutions were prepared fresh daily from concentrated stock solutions.
Statistical Analysis
MeanϮSEM was calculated for continuous variables, and absolute and relative frequencies were measured for discrete variables. Continuous variables were compared between groups with Student's t test or 1-way analysis of variance (ANOVA), and post hoc comparisons were performed with Bonferonni-corrected t tests, as appropriate. Categorical variables were compared with Fisher's exact test. The null hypothesis was rejected for PՅ0.05.
Results
W-7 Suppresses TdP Induction
In control animals treated with methoxamine and clofilium, a consistent evolutionary pattern of changes was observed. Bradycardia and QT prolongation were followed by fractionation of the T wave into 2 peaks (T and U), with a progressive increase in U-wave amplitude occurring immediately before After instrumentation and a 10-min stabilization period, W-7 or 5% dextrose solution (D5W) vehicle control and methoxamine were infused intravenously. W-7 or D5W was stopped after 10 min and clofilium infusion was started. Clofilium and methoxamine were continued for 30 min or until sustained TdP, whichever occurred first. 
QT and Heart Rate Are Not Affected by W-7
Bradycardia and QT prolongation are associated with TdP development in patients 22 and in this rabbit model. 18 Marked heart rate slowing and QT and QTc interval prolongation followed treatment with methoxamine and clofilium ( Figure  3 ), and these electrocardiographic parameters were similar in control and W-7-treated animals. Thus, suppression of TaP and PVCs by W-7 was not caused by effects on QT or QTc intervals, or heart rate, suggesting that cellular events reflected by these electrocardiographic parameters are insufficient for development of TdP.
W-7 Has No Effect on QT Dispersion
QT dispersion (QTd) may predict the arrhythmogenic potential of patients in whom cardiac repolarization is altered by drugs, 13 structural heart disease, 12 or the congenital long-QT syndromes. 15 QTd increased equally in W-7-and vehicletreated animals ( Figure 4 ). However, QTd increases did not reach statistical significance in either control (Pϭ0.27) or W-7-treated (Pϭ0.52) animals. These findings show that suppression of TdP by W-7 occurs in the absence of increases in QTd, suggesting that QTd does not reflect electrophysiological mechanisms fundamental to TdP in this model.
UTA Ratio Increases Predict TdP Initiation and Are Prevented by W-7
The QT split into 2 peaks (Figure 5 ), and the second peak (ie, the U wave) increased significantly in amplitude ( Figure 6 ) immediately before the first PVC. U waves were present in 7 of 9 rabbits before TdP onset but were present in only 3 of 12 rabbits without TdP (Pϭ0.03), suggesting that the presence of a U wave might reflect activation of cellular processes driven by Ca 2ϩ /CaM-dependent signaling and favoring TdP onset. This hypothesis was supported by the finding that U waves were only present in 2 of 11 rabbits treated with W-7 compared with 8 of 10 rabbits treated with control vehicle Figure 3 . W-7 does not prevent heart rate slowing or QT prolongation by methoxamine and clofilium. A, QT-interval durations increase significantly for both control (Pϭ0.001; open circles) and W-7-treated rabbits (PϽ0.001; filled circles). B, Heart rate is slowed significantly for both control (Pϭ0.001) and W-7-treated (PϽ0.001) rabbits. No significant differences were present between control and W-7 groups at any time point in panels A or B. C, Rate-corrected QT (QTc) also increased significantly for control (Pϭ0.02) and W-7-treated animals (PϽ0.001).
‡Pϭ0.028 between control and W-7-treated animals at the 4-min measurement. Significant changes compared with baseline (0 min) for individual points are indicated by * for controls and † for W-7-treated animals throughout. Numerals at the top of each panel indicate the number of animals measured for each data point; controls are the top numerals and W-7-treated animals are the bottom numerals. (Pϭ0.009). The UTA ratio was formulated to normalize U-wave amplitude changes to the T-wave amplitude, thereby minimizing potential differences in recordings between individual rabbits. The UTA ratio increased significantly (Pϭ0.008) immediately before PVC initiation in animals that developed TdP ( Figure 6B ), similar to changes seen in the U-wave amplitude ( Figure 6A ).
Discussion Electrocardiographic Parameters Associated With TdP
The QT duration and QTd are electrocardiographic parameters used to assess proarrhythmic potential of drugs, 23 congenital long-QT syndromes, 14, 15 and heart failure 24 in patients and in animal models. 18 The QT duration is advantageous because it can be performed rapidly, but its utility is reduced by technical difficulties with defining the end of the T wave 25 and by the fact that a threshold value for QT prolongation that reliably predicts arrhythmia remains undefined. 26, 27 QTd increases are associated with sudden cardiac death and TdP in some reports, 13,24,28 -30 but other reports show contrary findings, 16 and it remains uncertain which electrophysiological processes influence QTd. The finding that the increase in QTd before TdP was not significant is thus in line with some previous findings but not others. The fact that QTd increases only variably predict arrhythmia initiation is consistent with the possibility that different mechanisms may underlie TdP in various models and clinical settings. T-wave vector loops may prove to be a useful electrocardiographic tool for linking changes in ventricular repolarization 31 with various disease states. 32 However, presently available methods for T-wave vector loop acquisition and processing are cumbersome, and there is a paucity of data about underlying molecular and cellular mechanisms. Our finding that TdP can be suppressed without QT shortening by a CaM inhibitor motivated the present investigation for a novel electrocardiographic index linked to CaM-dependent cellular signaling. The UTA ratio offers important advantages over previously recognized electrocardiographic parameters, including a minimal requirement for data processing and independence from measuring the end of the T wave, which suggest the UTA ratio could be incorporated into algorithms for guiding drug or pacing therapies for TdP.
Molecular Mechanism for Electrocardiographic Changes in TdP
The present findings show that excessive prolongation of cardiac repolarization alone does not explain the mechanism for TdP. Action-potential prolongation by class III antiarrhythmic agents is disproportionately prolonged in M cells, and the repolarization gradient between M cells and more rapidly repolarizing cells in the epicardium and endocardium is hypothesized to account for the U wave and provide the functional substrate for maintenance of TdP. 19 Excessive prolongation of cardiac repolarization also increases intracellular Ca 2ϩ 7,10 and activates CaM and Ca 2ϩ /CaM-dependent protein kinase (CaMK). 33 Although CaM can activate diverse signaling molecules, recent evidence has specifically linked activation of CaMK to early 10, 33 and delayed 7 afterdepolarizations-both of which are hypothesized triggers for PVCs and TdP. CaMK is thought to stimulate early afterdepolarizations by increasing L-type Ca 2ϩ channel activity, 34 whereas other cellular studies have linked delayed afterdepolarizations to CaMK activation of inward Na ϩ /Ca 2ϩ exchanger current. 7 Afterdepolarizations most frequently arise in the M-cell layer and are thought to further increase the intramyocardial repolarization gradient, giving rise to giant U waves. 19 The finding that the UTA ratio was significantly suppressed by W-7 supports the novel hypothesis that U waves are critically dependent on afterdepolarizations that are activated by Ca 2ϩ /CaM.
Study Limitations
W-7 is an effective CaM-inhibitory agent, 35 but chemically related agents are also direct L-type Ca 2ϩ current antagonists. 33 Thus, observed effects on TdP could be by direct action at ion channel proteins, in addition to CaM inhibition. However, the present study and previous findings 9 showed that the concentration of W-7 used here does not reduce blood pressure, slow heart rate, or change the QT interval, suggesting that significant direct Ca 2ϩ channel antagonist action does not occur in vivo under our conditions. The protein kinase A inhibitory agent H-8 has recently been shown to suppress TdP, but only with concomitant QT shortening, 9 suggesting that separation of marked QT prolongation from TdP inducibility may be unique to CaM-inhibitory agents. Although the best evidence suggests that W-7's effects are likely due to inhibition of Ca 2ϩ /CaM-dependent kinase II, a more selective inhibitory agent will be required to definitively determine the Figure 6 . The UTA ratio increases significantly before PVC initiation. A, U-wave amplitude increases significantly before the first PVC (Pϭ0.021). In contrast, the T-wave amplitude does not increase significantly (Pϭ0.971) compared with baseline. The first time point (abscissa) is 12 min after initiating the experimental protocol (Figure 1) , and all data points after the break are marked by time before the first PVC for both panels. The numerals in the upper panel indicate the number of animals studied for each data point and apply to both panels. B, UTA ratio increases significantly compared with baseline (Pϭ0.008) before the first PVC in animals that developed TdP. *Significant increases compared with the first (12 min) data point.
specific CaM-activated molecular target responsible for U-wave amplitude increases and TdP.
